Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A NOVEL Observational longiTudinal studY on Patients With Asthma and/or COPD to Describe Patient Characteristics, Treatment Patterns and the Burden of Illness Over Time and to Identify Phenotypes and Endotypes.

NCT02760329 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02760329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02760329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A NOVEL Observational longiTudinal studY on Patients With Asthma and/or COPD to Describe Patient Characteristics, Treatment Patterns and the Burden of Illness Over Time and to Identify Phenotypes and Endotypes.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
July 25, 2016
Completion date
May 31, 2023
Enrollment
12,255 (actual)
Sites
331

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, chronic obstructive pulmonary disease, copd